Continuous versus intermittent inhaled corticosteroids for mild persistent asthma in children: Not too much, not too little

Thorax

Volumn 67, Issue 2, 2012, Pages 102-105

  Ducharme, Francine M ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BECLOMETASONE DIPROPIONATE PLUS SALBUTAMOL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUORINATED HYDROCARBON; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; TERBUTALINE; ZAFIRLUKAST;

BONE DENSITY; BRONCHUS HYPERREACTIVITY; CHILD; CHILD CARE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DISEASE CONTROL; DISEASE EXACERBATION; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; EDITORIAL; FORCED EXPIRATORY VOLUME; GROWTH RETARDATION; HUMAN; INTRAOCULAR PRESSURE; MEDICAL DECISION MAKING; MILD PERSISTENT ASTHMA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SAMPLE SIZE; SIDE EFFECT; SKINFOLD THICKNESS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 84856046182     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200961     Document Type: Editorial

References (34)

1. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. New Engl J Med 2006;354:1985-97.
2. Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40-7. (Pubitemid 39022491)
3. Halm EA, Mora P, Leventhal H. No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest 2006;129:573-80.
4. Pando S, Lemière C, Beauchesne MF, et al. Suboptimal use of inhaled corticosteroids in children with persistent asthma: inadequate prescription, poor drug adherence, or both? Pharmacotherapy 2010;30:1109-16.
5. Blais L, Kettani FZ, Lemière C, et al. Inhaled corticosteroids vs. leukotriene-receptor antagonists and asthma exacerbations in children. Respir Med 2011;105:846-55.
6. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81. (Pubitemid 24167107)
7. Montuschi P, Pagliari G, Fuso L. Pharmacotherapy of asthma: regular treatment or on demand? Ther Adv Respir Dis 2009;3:175-91.
8. Murray CS. Can inhaled corticosteroids influence the natural history of asthma? Curr Opin Allergy Clin Immunol 2008;8:77-81.
9. Cabana MD, Abu-Isa H, Thyne SM, et al. Specialty differences in prescribing inhaled corticosteroids for children. Clin Pediatr (Phila) 2007;46:698-705. (Pubitemid 47366767)
10. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005;115:132-8.
11. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129-36. (Pubitemid 40105411)
12. Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006;368:744-53. (Pubitemid 44279053)
13. Bisgaard H, Le Roux P, Bjamer D, et al. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest 2006;130:1733-43. (Pubitemid 46033427)
14. Haahtela T, Tamminen K, Malmberg LP, et al. Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. Eur Respir J 2006;28:748-55. (Pubitemid 46331995)
15. Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. New Engl J Med 2006;354:1998-2005.
16. Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009;360:339-53.
17. Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med 2007;175:323-9.
18. Boushey HA, Sorkness CA, King TS, et al. Daily versus as-needed corticosteroids for mild persistent asthma. New Engl J Med 2005;352:1519-28.
19. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007;356:2040-52. (Pubitemid 46789894)
20. Turpeinen M, Nikander K, Pelkonen AS, et al. Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study). Arch Dis Child 2008;93:654-9.
21. Martinez FD, Chinchilli VM, Morgan WJ, et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet 2011;377:650-7.
22. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 2001;107:706-11. (Pubitemid 32268455)
23. Mudd K, Bollinger ME, Hsu VD, et al. Pharmacy fill patterns in young urban children with persistent asthma. J Asthma 2006;43:597-600. (Pubitemid 44581254)
24. Walders N, Kopel SJ, Koinis-Mitchell D, et al. Patterns of quick-relief and long-term controller medication use in pediatric asthma. J Pediatr 2005;146:177-82. (Pubitemid 40202804)
25. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002;57:880-4. (Pubitemid 35178613)
26. Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 2000;106:E8.
27. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. New Engl J Med 2000;343:1054-63.
28. Von Berg A, Engelstatter R, Minic P, et al. Comparison of Ciclesonide 160ug/d with Budesonide 400ug/d in a Randomised Double-blind Study in Children with Moderate to Severe Asthma. Pediatr Allergy Immunol 2007;18:391-400.
29. Skoner DP, Maspero J, Banerji D. et al. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 2008;121:e1-14.
30. Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:5-34. (Pubitemid 350198248)
31. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008;32:1096-110.
32. Castro-Rodríguez JA, Holberg CJ, Wright AL, et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162:1403-6.
33. Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007;175:1304-45. (Pubitemid 46905757)
34. Bacharier LB. Does exhaled nitric oxide measurement help distinguish between wheezing phenotypes in preschool children? J Allergy Clin Immunol 2008;121:710-11.